Back to results

CompletedPhase 2

Clinical Study to Test a New Drug to Treat Major Depression

NCT00976560

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Hoffman Estates, Illinois, United States

+20 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2009-09-25
Enrollment: 128 participants
Sponsor: GlaxoSmithKline
Purpose: treatment

Locations (21)

GSK Investigational SiteHoffman Estates, Illinois, United States
GSK Investigational SitePark Ridge, Illinois, United States
GSK Investigational SiteNew York, New York, United States
GSK Investigational SiteColumbus, Ohio, United States
GSK Investigational SitePazardzhik, Bulgaria
GSK Investigational SitePlovdiv, Bulgaria
GSK Investigational SiteRousse, Bulgaria
GSK Investigational SiteSofia, Bulgaria
GSK Investigational SiteTartu, Estonia
GSK Investigational SiteHüttenberg, Hesse, Germany
GSK Investigational SiteAchim, Lower Saxony, Germany
GSK Investigational SiteWesterstede, Lower Saxony, Germany
GSK Investigational SiteSchwerin, Mecklenburg-Vorpommern, Germany
GSK Investigational SiteBielefeld, North Rhine-Westphalia, Germany
GSK Investigational SiteDresden, Saxony, Germany
GSK Investigational SiteBerlin, Germany
GSK Investigational SiteMoscow, Russia
GSK Investigational SiteMoscow, Russia
GSK Investigational SiteSaint Petersburg, Russia
GSK Investigational SiteSamara, Russia
GSK Investigational SiteSmolensk, Russia

Clinical Study to Test a New Drug to Treat Major Depression — TrialFind